BioCentury
ARTICLE | Company News

BioDelivery, KunWha Pharmaceutical sales and marketing update

June 7, 2010 7:00 AM UTC

BioDelivery granted KunWha exclusive rights to develop and commercialize BEMA fentanyl ( Onsolis) in South Korea. The adhesive disc formulation of fentanyl is approved in the U.S. and Canada and unde...